The African Swine Fever (ASF) Diagnostics and Prevention Market has become a priority segment in global swine health management due to the devastating impact of ASF outbreaks across Asia, Europe, and Africa. ASF has resulted in the death or culling of millions of pigs worldwide, disrupting pork supply chains and creating a pressing demand for effective diagnostics, surveillance, and biosecurity tools. In 2024, the global ASF diagnostics and prevention market is valued at USD 1.3 billion and is projected to reach USD 2.65 billion by 2031, growing at a CAGR of 10.4%.

Key Market Drivers

Ongoing Global Outbreaks: China, Vietnam, the Philippines, and parts of Europe continue to experience sporadic outbreaks, prompting government and private investments in diagnostics and biosecurity.

Lack of Commercial Vaccine: Without an approved commercial ASF vaccine (as of 2024), prevention relies heavily on early detection, surveillance, and control measures at the farm level.

Supply Chain Disruptions: ASF-induced culling and trade bans have increased investment in farm-level testing kits and secure transportation protocols.

Market Segmentation

By Product Type

• Diagnostic Kits (50%): PCR, ELISA, and rapid test kits
• Biosecurity Products (XX%): Disinfectants, farm access controls, PPE
• Surveillance and Monitoring Tools (XX%): GIS, portable detectors, AI-based monitoring

By Deployment Site

• On-Farm Use (XX%)
• Laboratory Testing (XX%)
• Border/Quarantine Checkpoints (15%)

By Region

• Asia-Pacific (44%): China, Vietnam, and South Korea driving adoption
• Europe (XX%): Germany, Poland, and Eastern Europe expanding surveillance
• Africa & Latin America (XX%): Disease hotspots with limited infrastructure
• North America (XX%): Focus on prevention and border control preparedness

Competitive Landscape

Global and regional players are innovating with mobile diagnostics, AI tools, and cross-border ASF control initiatives:

• IDEXX Laboratories – High-throughput ELISA kits for surveillance networks
• Thermo Fisher Scientific – Real-time PCR diagnostic platforms
• Boehringer Ingelheim – Investing in ASF vaccine research and biosecurity services
• INIA (Spain) – Leading public research on ASF genomic monitoring
• Mekong ASF Response Consortium – Regional collaboration for field diagnostics in Southeast Asia

Emerging Trends

AI and Digital Surveillance: Smart sensors and mobile apps monitor symptoms, mortality patterns, and biosecurity breaches in real time.

Portable Diagnostic Devices: Handheld PCR and rapid antigen testing kits are facilitating quicker outbreak responses.

ASF Vaccine R&D Acceleration: Several vaccine candidates are entering field trials, raising hopes for market availability after 2026.

Regional Disease-Free Zoning: Geographic segregation strategies are being digitally mapped and verified to facilitate trade.

Regulatory Landscape

ASF is a notifiable disease under OIE (World Organisation for Animal Health) guidelines. National governments are mandating surveillance protocols, testing procedures, and reporting within 24 hours. International trade policies are being aligned to recognize zoning and compartmentalization practices for ASF-free exports.